Your institution may have access to this item. Find your institution then sign in to continue.
Title
NEWS IN BRIEF.
Abstract
Reports on developments in the drug industry as of May 2004. Multimillion dollar deal between Aventis and Sanofi to divest Sanofi's antithrombosis drugs to GlaxoSmithKline; Announcement of Merck and Schering-Plough that Mexico and Germany had approved their simvastatin/ezetimbe combination treatment; Revelation of Human Genome Sciences that it is halting development of around half the drugs in development.